RNU6-175P

Across TCGA pan-cancer cohorts, RNU6-175P RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated RNU6-175P data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher RNU6-175P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-175P expression acts as an unfavorable survival marker.

BRCA, KIRC, and HNSC are the cancer types where RNU6-175P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	DFS	Tertile	III,IV	0.327	0.796	.024	36	view →
KIRC	DFS	Tertile	IV	0.206	0.623	.021	18	view →
HNSC	OS	Tertile	All	0.167	0.710	.005	18	view →
LAML	DFS	Tertile	All	0.028	0.583	.001	18	view →
CESC	OS	Tertile	All	0.271	0.798	.010	18	view →
THCA	DFS	Tertile	All	0.825	0.935	.036	9	view →
GBM	OS	Tertile	All	0.203	0.422	.038	9	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

RNU6-175P–BRCA (DFS)

Open the BRCA breakdown →